&nbsp;

Sep 2025

Drug

pegylated liposomal DOXOrubicin

Other Name(s): Caelyx®

Quick Link(s):

Sep 2025

Drug

cyclophosphamide

Other Name(s): Procytox®

Quick Link(s):

Oct 2020

Drug

iBRUtinib

Other Name(s): Imbruvica®

Quick Link(s):

Jan 2026

Regimen

GEMC

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2020

Regimen

GEMC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2020

Regimen

SUNI

Cancer Type:

Gastrointestinal,

Gastrointestinal Stromal Tumours,

Sarcoma,

GIST

Intent: Palliative

Funding:

Exceptional Access Program

SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria

Drugs Used:

SUNItinib

Quick Link(s):

Regimen Monograph

Oct 2020

Regimen

GEMC

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2020

Regimen

GEMC

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2020

Regimen

SUNI

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

Exceptional Access Program

SUNItinib - Metastatic renal cell carcinoma, with specific criteria

Drugs Used:

SUNItinib

Quick Link(s):

Regimen Monograph

Oct 2020

Regimen

SORA

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

Exceptional Access Program

SORAfenib - Metastatic renal cell carcinoma of clear cell histology as second-line treatment, with specific criteria

Drugs Used:

SORAfenib

Oct 2020

Regimen

GEMC

Cancer Type:

Breast

Intent: Palliative

Drugs Used: